K. B. Walker, M. J. Brennan, M. M. Ho, J. Eskola, G. Thiry, J. Sadoff, R. Dobbelaer, L. Grode, M. A. Liu, U. Fruth and P. H. Lambert, “The Second Geneva Consensus: Recommendations for Novel Live TB Vaccines,” Vaccine, Vol. 28, No. 11, 2010, pp. 2259-2270. doi:10.1016/j.vaccine.2009.12.083

has been cited by the following article:

• TITLE: Clinical Outcome of Children with Post Bacillus Calmette and Guerin Vaccination Complications: A Single Center Experience

  AUTHORS: Nermeen M. Galal

  KEYWORDS: BCG Related Complications; Primary Immunodeficiency

  JOURNAL NAME: World Journal of Vaccines, Vol.2 No.1, February 17, 2012

  ABSTRACT: Background: Bacillus Calmette ET Guerin (BCG) vaccine, compulsory in endemic areas, remains the only available vaccine for prevention of Tuberculosis (TB) despite its modest protective value. Complications may arise in healthy/ immunocompromized hosts. Methods: Children presenting with BCG vaccine related complications in the form of local/distant complications were enrolled from 2007-2010 at Cairo University Pediatric hospital. Objectives: assess outcome of BCG related complications in a group of children with post vaccination incidents, identify risk factors for complications among vaccinated children and identify cases of underlying Primary Immunodeficiency (PID) among presenting cases. Results: Fifty one eligible patients were included, forty three were proved immunocompetent, and eight had underlying primary immunodeficiency disorders. Presentations included localized axillary lymphadenopathy, cervical sinuses, granulomatous lesions and disseminated forms Faulty injection sites were strongly associated with complications (p value